(NASDAQ: LNSR) Lensar's forecast annual revenue growth rate of 46.94% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,573.61%.
Lensar's revenue in 2026 is $59,141,000.On average, 3 Wall Street analysts forecast LNSR's revenue for 2026 to be $1,038,028,826, with the lowest LNSR revenue forecast at $997,321,813, and the highest LNSR revenue forecast at $1,068,559,085.
In 2027, LNSR is forecast to generate $1,352,361,498 in revenue, with the lowest revenue forecast at $1,299,327,714 and the highest revenue forecast at $1,392,136,836.